In This Issue
18F-Deoxyglucose Uptake in Stage I Non–Small-Cell Lung Cancer
Lung Cancer Stem Cell
Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative Reverse Transcription Polymerase Chain Reaction Assays
Transbronchial Biopsy Needle Rinse Solution Used for Comprehensive Biomarker Testing in Patients with Lung Cancer
Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer
Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer
Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients
Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy
Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules
Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer
Clinical Characteristics and Treatment Outcomes of Lung Adenocarcinomas with Discrepant EGFR Mutation Testing Results Derived from PCR-Direct Sequencing and Real-Time PCR-Based Assays
Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement
Preselection Based on Clinical Characteristics in German Non–Small-Cell Lung Cancer Patients Screened for EML4-ALK Translocation
A Brief Report of 10-Year Trends in the Use of Stereotactic Lung Radiotherapy at a Dutch Academic Medical Center
RET Rearrangements in Lung Adenocarcinoma and Radiation
Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer
Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer
Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal Carcinoid
Unsuspected Collision of Synchronous Lung Adenocarcinomas
Complete Pathologic Response in Soft Tissue Sarcoma Lung Metastases with Pazopanib
Consolidation Chemotherapy after Concurrent Radiochemotherapy in Locally Advanced Non–small-Cell Lung Cancer May Have Been Beneficial if We Only Knew Where It Have Worked
Role of Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer
Lung Adenocarcinoma with Ipsilateral Pleural and Breast Metastases